Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up

BACKGROUND: Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump is a treatment option for patients with type 1 diabetes mellitus (T1DM). Aim of the present study was to describe the long-term course of glycaemic control, complications, health related quality of life (HRQOL)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: van Dijk, Peter R, Logtenberg, Susan JJ, Groenier, Klaas H, Gans, Rijk OB, Kleefstra, Nanne, Bilo, Henk JG
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2014
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4029992/
https://ncbi.nlm.nih.gov/pubmed/24708696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6823-14-30
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak